Category: Feature Article
PD-1/PD-L1 Immune Checkpoint Blockade in Non–Small Cell Lung Cancer
Stephen J. Bagley, MD, Joshua M. Bauml, MD, and Corey J. Langer, MD The authors are affiliated with the division of hematology/oncology at the Abramson Cancer […]
Adjuvant Endocrine Therapy in Premenopausal Women With Breast Cancer
Kunal C. Kadakia, MD, and N. Lynn Henry, MD, PhD The authors are affiliated with the University of Michigan Comprehensive Cancer Center. Dr Kadakia is a […]
Monoclonal Antibodies in Myeloma
Clinical Advances in Hematology & Oncology Volume 13, Issue 9, September 2015 Pia Sondergeld, PhD, Niels W. C. J. van de Donk, MD, PhD, Paul G. Richardson, […]
New Insights Into Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia: A 2015 Perspective
Fabienne McClanahan, MD, PhD, and John Gribben, MD, DSc, FRCP, FRCPath, FMedSci Dr McClanahan is a Clinical Research Fellow in the Centre for Haemato-Oncology at the […]
Managing Acquired Resistance in EGFR-Mutated Non–Small Cell Lung Cancer
Clinical Advances in Hematology & Oncology August 2015, Volume 13, Issue 8 Patrick M. Forde, MD, and David S. Ettinger, MD The authors are […]
Hodgkin Lymphoma: Targeting the Tumor Microenvironment as a Therapeutic Strategy
Clinical Advances in Hematology & Oncology August 2015, Volume 13, Issue 8 Francesca Montanari, MD, and Catherine S. M. Diefenbach, MD The authors are affiliated […]
The Effect of Cancer Treatment on Cognitive Function
Clinical Advances in Hematology & Oncology July 2015, Volume 13, Issue 7 Arash Asher, MD, and Jamie S. Myers, PhD, RN, AOCNS Dr Asher is […]
Immunotherapy or Molecularly Targeted Therapy: What Is the Best Initial Treatment for Stage IV BRAF-Mutant Melanoma?
Clinical Advances in Hematology & Oncology July 2015, Volume 13, Issue 7 Geoffrey T. Gibney, MD, and Michael B. Atkins, MD Geoffrey T. Gibney, MD, […]
Renal Cell Carcinoma in Patients With a Personal or Family History of Hematologic Malignancies
Volume 13, Issue 6 June 2015 Janice P. Dutcher, MD, and Peter H. Wiernik, MD The authors are affiliated with the Cancer Research Foundation of New York in […]
Non–Clear Cell Renal Cell Carcinoma, Part 2: Therapy
Volume 13, Issue 6 June 2015 Loana B. Valenca, MD, Michelle S. Hirsch, MD, PhD, Toni K. Choueiri, MD, and Lauren C. Harshman, MD The authors are […]
Immunology and Breast Cancer: Toward a New Way of Understanding Breast Cancer and Developing Novel Therapeutic Strategies
Volume 13, Issue 6 June 2015 Isabelle Gingras, MD, Hatem A. Azim Jr, MD, PhD, Michail Ignatiadis, MD, PhD, and Christos Sotiriou, MD, PhD The authors are […]
Cancer Immunology for the Clinician
Clinical Advances in Hematology & Oncology May 2015, Volume 13, Issue 5 Louis M. Weiner, MD Dr Weiner is the director of the Georgetown Lombardi […]
Non–Clear Cell Renal Cell Carcinoma, Part 1: Histology
Clinical Advances in Hematology & Oncology May 2015, Volume 13, Issue 5 Loana B. Valenca, MD, Michelle S. Hirsch, MD, PhD, Toni K. Choueiri, […]
How We Treat Systemic Light-Chain Amyloidosis
Clinical Advances in Hematology & Oncology May 2015, Volume 13, Issue 5 Chakra P. Chaulagain, MD, and Raymond L. Comenzo, MD Dr Chaulagain is an […]
Novel Therapeutic Targets in Multiple Myeloma
Clinical Advances in Hematology & Oncology April 2015, Volume13, Issue 4 Novel Therapeutic Targets in Multiple Myeloma Francesca Cottini, MD, and Kenneth Anderson, MD Dr Cottini […]
Curative Treatment for Severe Sickle Cell Disease: Allogeneic Transplantation
Clinical Advances in Hematology & Oncology April 2015, Volume 13, Issue 4 Curative Treatment for Severe Sickle Cell Disease: Allogeneic Transplantation Benjamin Oshrine, MD, and […]
Families With Both Hodgkin Lymphoma and Multiple Myeloma in Their Pedigrees
Clinical Advances in Hematology & Oncology April 2015, Volume 13, Issue 4 Families With Both Hodgkin Lymphoma and Multiple Myeloma in Their Pedigrees Peter H. […]
Key Statistical Concepts in Cancer Research
Clinical Advances in Hematology & Oncology March 2015, Volume 13, Issue 3 Qian Shi, PhD, and Daniel J. Sargent, PhD The authors are affiliated with […]
Review of Treatment Options for Oligometastatic Non–Small Cell Lung Cancer
Clinical Advances in Hematology & Oncology March 2015, Volume 13, Issue 3 Michael R. Folkert, MD, PhD, and Robert Timmerman, MD The authors are affiliated […]
Long-term Toxicity of Chemotherapy and Radiotherapy in Lymphoma Survivors: Optimizing Treatment for Individual Patients
Clinical Advances in Hematology & Oncology February 2015, Volume 13, Issue 2 David C. Hodgson, MD, MPH, FRCPC Dr Hodgson is an associate professor in […]